{"pmid":32439870,"title":"COVID-19: the vasculature unleashed.","text":["COVID-19: the vasculature unleashed.","Nat Rev Immunol","Teuwen, Laure-Anne","Geldhof, Vincent","Pasut, Alessandra","Carmeliet, Peter","32439870"],"journal":"Nat Rev Immunol","authors":["Teuwen, Laure-Anne","Geldhof, Vincent","Pasut, Alessandra","Carmeliet, Peter"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439870","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41577-020-0343-0","topics":["Mechanism","Treatment"],"weight":1,"_version_":1667535119477374977,"score":9.490897,"similar":[{"pmid":32499635,"title":"Author Correction: COVID-19: the vasculature unleashed.","text":["Author Correction: COVID-19: the vasculature unleashed.","An amendment to this paper has been published and can be accessed via a link at the top of the paper.","Nat Rev Immunol","Teuwen, Laure-Anne","Geldhof, Vincent","Pasut, Alessandra","Carmeliet, Peter","32499635"],"abstract":["An amendment to this paper has been published and can be accessed via a link at the top of the paper."],"journal":"Nat Rev Immunol","authors":["Teuwen, Laure-Anne","Geldhof, Vincent","Pasut, Alessandra","Carmeliet, Peter"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499635","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41577-020-0356-8","link_erratum_for":"32439870","weight":0,"_version_":1668804508973531136,"score":80.323494},{"pmid":32468151,"title":"The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?","text":["The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?","The novel coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sorely testing health care systems and economies around the world and is rightly considered as the major health emergency in a century. Despite the course of the disease appearing to be mild in many cases, a significant proportion of symptomatic patients develop pneumonia requiring hospitalisation or progress to manifest respiratory complications leading to intensive care treatment. Potential interventions for SARS-CoV2-associated pneumonia are being tested, some of which holding promise, but as of today none of these has yet demonstrated outstanding efficacy in treating COVID-19. In this article, we discuss fresh perspectives and insights into the potential role of immune dysregulation in COVID-19 as well as similarities with systemic inflammatory response in sepsis and the rationale for exploring novel treatment options affecting host immune response.","Inflamm Res","Bellinvia, Salvatore","Edwards, Christopher J","Schisano, Matteo","Banfi, Paolo","Fallico, Matteo","Murabito, Paolo","32468151"],"abstract":["The novel coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is sorely testing health care systems and economies around the world and is rightly considered as the major health emergency in a century. Despite the course of the disease appearing to be mild in many cases, a significant proportion of symptomatic patients develop pneumonia requiring hospitalisation or progress to manifest respiratory complications leading to intensive care treatment. Potential interventions for SARS-CoV2-associated pneumonia are being tested, some of which holding promise, but as of today none of these has yet demonstrated outstanding efficacy in treating COVID-19. In this article, we discuss fresh perspectives and insights into the potential role of immune dysregulation in COVID-19 as well as similarities with systemic inflammatory response in sepsis and the rationale for exploring novel treatment options affecting host immune response."],"journal":"Inflamm Res","authors":["Bellinvia, Salvatore","Edwards, Christopher J","Schisano, Matteo","Banfi, Paolo","Fallico, Matteo","Murabito, Paolo"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468151","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s00011-020-01366-6","keywords":["checkpoint inhibitors","covid-19","cytokine storm","immune dysregulation","inflammatory receptors","sepsis"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668420887162912768,"score":50.726837}]}